Nabriva Therapeutics plc (NBRVF)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Mar 3, 2026
Nabriva Therapeutics Market Cap
Nabriva Therapeutics has a market cap or net worth of $646.00 as of March 9, 2026. Its market cap has decreased by -99.99% in one year.
Market Cap
646.00
Enterprise Value
n/a
Revenue
29.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 18, 2015, Nabriva Therapeutics's market cap has decreased from 26.22M to 646.00, a decrease of -100.00%. That is a compound annual growth rate of -63.73%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amarantus BioScience Holdings | 630.00 |
| Pathfinder Cell Therapy | 667.00 |
| Adynxx | 581.00 |
| Mera Pharmaceuticals | 537.00 |
| Tetra Bio-Pharma | 516.00 |
| RegeneRx Biopharmaceuticals | 453.00 |
| Alzex Neuropharma | 452.00 |
| eFFECTOR Therapeutics | 941.00 |